Michael Cherny
Stock Analyst at B of A Securities
(n/a)
# 5
Out of 4,829 analysts
109
Total ratings
n/a
Success rate
-77.84%
Average return
Main Sectors:
Stocks Rated by Michael Cherny
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Buy | $755 → $800 | $687.52 | +16.36% | 13 | May 9, 2025 | |
| NVST Envista Holdings | Maintains: Buy | $26 → $23 | $18.56 | +23.92% | 11 | Apr 29, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $150 → $155 | $148.62 | +4.29% | 11 | Apr 11, 2025 | |
| MEDP Medpace Holdings | Initiates: Market Perform | $330 | $313.74 | +5.18% | 1 | Mar 24, 2025 | |
| HIMS Hims & Hers Health | Maintains: Market Perform | $24 → $40 | $55.21 | -27.55% | 10 | Feb 25, 2025 | |
| CVS CVS Health | Upgrades: Outperform | $55 → $75 | $64.81 | +15.72% | 11 | Feb 13, 2025 | |
| PGNY Progyny | Maintains: Buy | $21 → $25 | $22.00 | +13.64% | 10 | Feb 11, 2025 | |
| DOCS Doximity | Upgrades: Outperform | $60 → $90 | $61.04 | +47.44% | 2 | Feb 7, 2025 | |
| ALGN Align Technology | Upgrades: Outperform | $235 → $280 | $189.00 | +48.15% | 2 | Jan 6, 2025 | |
| DGX Quest Diagnostics | Upgrades: Outperform | $135 → $174 | $175.90 | -1.08% | 2 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $69 → $84 | $70.47 | +19.20% | 2 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $260 → $248 | $156.13 | +58.84% | 2 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $270 → $255 | $140.22 | +81.86% | 3 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $16.75 | - | 8 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $277 → $275 | $278.38 | -1.21% | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $25 | $1.49 | +1,577.85% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $23 → $22 | $11.40 | +92.98% | 2 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $260 | $250.94 | +3.61% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $23 | $23.01 | -2.22% | 5 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $8 | $4.35 | +83.91% | 5 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $19 | $12.13 | +56.64% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $17 | $7.36 | +130.98% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $113 → $53 | $8.13 | +545.76% | 2 | Jan 5, 2022 |
McKesson
May 9, 2025
Maintains: Buy
Price Target: $755 → $800
Current: $687.52
Upside: +16.36%
Envista Holdings
Apr 29, 2025
Maintains: Buy
Price Target: $26 → $23
Current: $18.56
Upside: +23.92%
Cardinal Health
Apr 11, 2025
Maintains: Buy
Price Target: $150 → $155
Current: $148.62
Upside: +4.29%
Medpace Holdings
Mar 24, 2025
Initiates: Market Perform
Price Target: $330
Current: $313.74
Upside: +5.18%
Hims & Hers Health
Feb 25, 2025
Maintains: Market Perform
Price Target: $24 → $40
Current: $55.21
Upside: -27.55%
CVS Health
Feb 13, 2025
Upgrades: Outperform
Price Target: $55 → $75
Current: $64.81
Upside: +15.72%
Progyny
Feb 11, 2025
Maintains: Buy
Price Target: $21 → $25
Current: $22.00
Upside: +13.64%
Doximity
Feb 7, 2025
Upgrades: Outperform
Price Target: $60 → $90
Current: $61.04
Upside: +47.44%
Align Technology
Jan 6, 2025
Upgrades: Outperform
Price Target: $235 → $280
Current: $189.00
Upside: +48.15%
Quest Diagnostics
Jan 6, 2025
Upgrades: Outperform
Price Target: $135 → $174
Current: $175.90
Upside: -1.08%
Jan 6, 2025
Upgrades: Buy
Price Target: $69 → $84
Current: $70.47
Upside: +19.20%
Nov 19, 2024
Reiterates: Outperform
Price Target: $260 → $248
Current: $156.13
Upside: +58.84%
Nov 19, 2024
Reiterates: Outperform
Price Target: $270 → $255
Current: $140.22
Upside: +81.86%
Nov 7, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $16.75
Upside: -
Oct 7, 2024
Maintains: Outperform
Price Target: $277 → $275
Current: $278.38
Upside: -1.21%
Apr 22, 2024
Initiates: Outperform
Price Target: $25
Current: $1.49
Upside: +1,577.85%
Mar 18, 2024
Maintains: Market Perform
Price Target: $23 → $22
Current: $11.40
Upside: +92.98%
Feb 26, 2024
Initiates: Outperform
Price Target: $260
Current: $250.94
Upside: +3.61%
Feb 26, 2024
Initiates: Market Perform
Price Target: $23
Current: $23.01
Upside: -2.22%
Feb 26, 2024
Initiates: Outperform
Price Target: $8
Current: $4.35
Upside: +83.91%
Feb 26, 2024
Initiates: Market Perform
Price Target: $19
Current: $12.13
Upside: +56.64%
Feb 26, 2024
Initiates: Market Perform
Price Target: $17
Current: $7.36
Upside: +130.98%
Jan 5, 2022
Downgrades: Underperform
Price Target: $113 → $53
Current: $8.13
Upside: +545.76%